Billion Dollar #Biotech #VentureCapital Boom | MIT Technology Review


Venture Capitalists Love Biotech Right Now Scientific advances and new business models are spurring investor confidence in biomedical-related ventures. By Mike Orcutt on February 24, 2015 Why It Matters Developing innovative drugs, therapies, and devices is often extremely expensive. Venture capital investment in U.S. life sciences companies soared 29 percent in 2014 from the year before, reaching $8.6 billion, the highest level since 2007. And there is reason to think 2015 will also be a big year for a sector having its third boom of the last two decades.1 Biotech is the second biggest category for venture investment after software. … Continue reading Billion Dollar #Biotech #VentureCapital Boom | MIT Technology Review

#CEO Lie Detector: Putting your candor where your mouth is = #AlignedValue


New approaches to financial analysis measures executive evasion and candor to gauge a company’s outlook. Did you know… Audiogram software can assess tonal inflections, volume, and other vocal indicators to infer executive confidence or stress. Forensic Accountants and Fund Managers are using this technology right now to assess the credibility of CEO and CFO commentary during earnings calls. Executive judgement can play a bigger role in company valuations, profit and loss statements, and forecasts than data. According to Jason Voss, Content Director at the CFA Institute, “Data is an outcome, but people create the data.”  Mr. Voss helps train analysts and … Continue reading #CEO Lie Detector: Putting your candor where your mouth is = #AlignedValue

Successful Turnaround via Positive Cultural Change | Chief Executive magazine #CEO #AlignedValue


 3 Tactics for Creating a Successful Turnaround Through Positive Cultural Change Not many companies have had as much tumult lately as Sprint, which, in February, took a $1.9-billion quarterly write-off because of the reduced value of its trade name. The company’s stock price is down by more than 50%, from a high of $9.74 in June, 2014 to $4.28 on February 26, 2015, but the sale price has somewhat stabilized over the last 30 days. The highs and lows can be attributed to CEO Marcelo Claure, who, in little more than a half-year at the helm of the third largest … Continue reading Successful Turnaround via Positive Cultural Change | Chief Executive magazine #CEO #AlignedValue